These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. Dupuis-Girod S; Ginon I; Saurin JC; Marion D; Guillot E; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Lorcerie B; Rivière S; Corre R; Giraud S; Bailly S; Paintaud G; Ternant D; Valette PJ; Plauchu H; Faure F JAMA; 2012 Mar; 307(9):948-55. PubMed ID: 22396517 [TBL] [Abstract][Full Text] [Related]
6. [Bevacizumab in therapy-refractory epistaxis: case report of low-dose antibody therapy for hereditary hemorrhagic telangiectasia]. Rohrmeier C; Kühnel TS HNO; 2012 Nov; 60(11):1003-6. PubMed ID: 22706563 [TBL] [Abstract][Full Text] [Related]
7. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329 [TBL] [Abstract][Full Text] [Related]
8. Intranasal bevacizumab in the treatment of HHT -related epistaxis: a systematic review. Stokes P; Rimmer J Rhinology; 2018 Mar; 56(1):3-10. PubMed ID: 29166422 [TBL] [Abstract][Full Text] [Related]
9. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose. Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282 [TBL] [Abstract][Full Text] [Related]
10. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis. Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816 [TBL] [Abstract][Full Text] [Related]
11. Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia. Khoueir N; Borsik M; Camous D; Herman P; Verillaud B Laryngoscope; 2019 Oct; 129(10):2210-2215. PubMed ID: 31566760 [TBL] [Abstract][Full Text] [Related]
12. Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT). Chavan A; Schumann-Binarsch S; Luthe L; Nickau B; Elsässer A; Kühnel T; Geisthoff U; Köhne H Vasa; 2013 Mar; 42(2):106-10. PubMed ID: 23485837 [TBL] [Abstract][Full Text] [Related]
16. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia. Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219 [TBL] [Abstract][Full Text] [Related]